Society for Endocrinology - a world-leading authority on hormones

News

New oral hormone drug for prostate cancer

22 Dec 2020



The Food and Drug Administration has approved the use of a new oral hormone therapy drug, Relugolix, for treating advanced prostate cancer in men.

Healio